Advertisement
Advertisement

CLNN

CLNN logo

Clene Inc. Common Stock

5.77
USD
Sponsored
-0.12
-2.04%
Jun 23, 16:00 UTC -4
Closed
exchange

After-Market

5.68

-0.09
-1.58%

CLNN Earnings Reports

Positive Surprise Ratio

CLNN beat 12 of 22 last estimates.

55%

Next Report

Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
$74.97K
/
-$0.37
Implied change from Q1 26 (Revenue/ EPS)
+399.80%
/
+37.04%
Implied change from Q2 25 (Revenue/ EPS)
+177.67%
/
-52.56%

Clene Inc. Common Stock earnings per share and revenue

On May 14, 2026, CLNN reported earnings of -0.27 USD per share (EPS) for Q1 26, beating the estimate of -0.64 USD, resulting in a 58.42% surprise. Revenue reached 15.00 thousand, compared to an expected 41.41 thousand, with a -63.78% difference. The market reacted with a +8.46% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.37 USD, with revenue projected to reach 74.97 thousand USD, implying an increase of 37.04% EPS, and increase of 399.80% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
logo
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Clene Inc. Common Stock reported EPS of -$0.27, beating estimates by 58.42%, and revenue of $15.00K, -63.78% below expectations.
The stock price moved up 8.46%, changed from $6.50 before the earnings release to $7.05 the day after.
The next earning report is scheduled for Aug 12, 2026.
Based on 5 analysts, Clene Inc. Common Stock is expected to report EPS of -$0.37 and revenue of $74.97K for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement